![Bacteria / Tuberculosis treatment / Multi-drug-resistant tuberculosis / Pyrazinamide / Latent tuberculosis / Rifampicin / Extensively drug-resistant tuberculosis / Isoniazid / Moxifloxacin / Tuberculosis / Medicine / Chemistry Bacteria / Tuberculosis treatment / Multi-drug-resistant tuberculosis / Pyrazinamide / Latent tuberculosis / Rifampicin / Extensively drug-resistant tuberculosis / Isoniazid / Moxifloxacin / Tuberculosis / Medicine / Chemistry](https://www.pdfsearch.io/img/5ec2415660386aec54bcfd6e215e8646.jpg) Date: 2010-05-19 10:24:07Bacteria Tuberculosis treatment Multi-drug-resistant tuberculosis Pyrazinamide Latent tuberculosis Rifampicin Extensively drug-resistant tuberculosis Isoniazid Moxifloxacin Tuberculosis Medicine Chemistry | | Series Tuberculosis 5 Global tuberculosis drug development pipeline: the need and the reality Zhenkun Ma, Christian Lienhardt, Helen McIlleron, Andrew J Nunn, Xiexiu WangAdd to Reading ListSource URL: www.stoptb.orgDownload Document from Source Website File Size: 296,72 KBShare Document on Facebook
|